John Papandrea

Amministratore Delegato presso Focal Therapeutics, Inc.

Consumer Services

Technology Services

Health Technology

Profilo

John Papandrea is currently the Chief Executive Officer at Focal Therapeutics, Inc. Prior to this, he was a Senior Vice President at SAP SE from 2011 to 2012.
He has a graduate degree from The University of New South Wales and an undergraduate degree from the University of Technology Sydney.

Posizioni attive di John Papandrea

Società	Posizione	Inizio
Focal Therapeutics, Inc. Focal Therapeutics, Inc. Medical SpecialtiesHealth Technology Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.	Amministratore Delegato	-

Tutte le posizioni attive di John Papandrea

Precedenti posizioni note di John Papandrea

Società	Posizione	Fine
SAP SE	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di John Papandrea

Formazione di John Papandrea

University of Technology Sydney	Undergraduate Degree
The University of New South Wales	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John Papandrea

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SAP SE	Technology Services

Aziende private	1
Focal Therapeutics, Inc. Focal Therapeutics, Inc. Medical SpecialtiesHealth Technology Focal Therapeutics, Inc. develops and manufactures medical devices. Its product BioZorb tissue marker, is a proprietary bioabsorbable device that provides radiographic marking of soft tissue sites. The firm’s product is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up. The company was founded in 2007 by George D. Hermann and James B. Stubbs and is headquartered in Aliso Viejo, CA.	Health Technology